BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

42 related articles for article (PubMed ID: 8489488)

  • 1. Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
    Ruike Y; Suzuki S; Yokote K
    Clin Nucl Med; 2024 May; 49(5):419-426. PubMed ID: 38546331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Subclinical phaeochromocytoma.
    Mannelli M; Lenders JW; Pacak K; Parenti G; Eisenhofer G
    Best Pract Res Clin Endocrinol Metab; 2012 Aug; 26(4):507-15. PubMed ID: 22863392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical Characteristics and Outcome of Patients With Pheochromocytoma: A Single Center Tertiary Care Experience.
    Sohail S; Shafiq W; Raza SA; Zahid A; Mir K; Azmat U
    Cureus; 2020 May; 12(5):e7990. PubMed ID: 32523845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 123I-MIBG scintigraphy and 18F-FDG-PET imaging for diagnosing neuroblastoma.
    Bleeker G; Tytgat GA; Adam JA; Caron HN; Kremer LC; Hooft L; van Dalen EC
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD009263. PubMed ID: 26417712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Measurement of fractionated plasma metanephrines for exclusion of pheochromocytoma: Can specificity be improved by adjustment for age?
    Sawka AM; Thabane L; Gafni A; Levine M; Young WF
    BMC Endocr Disord; 2005 Feb; 5(1):1. PubMed ID: 15737232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endoscopic retroperitoneal adrenalectomy: lessons learned from 111 consecutive cases.
    Bonjer HJ; Sorm V; Berends FJ; Kazemier G; Steyerberg EW; de Herder WW; Bruining HA
    Ann Surg; 2000 Dec; 232(6):796-803. PubMed ID: 11088074
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiopharmaceutical diagnosis and therapy of sympatho-medullary disorders.
    Shapiro B
    Ann Nucl Med; 1996 Feb; 10(1):9-12. PubMed ID: 8814734
    [No Abstract]   [Full Text] [Related]  

  • 8. Where are we with nuclear medicine in pediatrics?
    Nadel HR
    Eur J Nucl Med; 1995 Dec; 22(12):1433-51. PubMed ID: 8586090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Death from phaeochromocytoma: lessons from a post-mortem survey.
    Platts JK; Drew PJ; Harvey JN
    J R Coll Physicians Lond; 1995; 29(4):299-306. PubMed ID: 7473324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [131I-meta-iodobenzylguanidine (MIBG) for the detection and therapy of pheochromocytoma and neuroblastoma].
    Nakajo M; Shinohara S
    Rinsho Hoshasen; 1987 Apr; 32(4):461-70. PubMed ID: 3613180
    [No Abstract]   [Full Text] [Related]  

  • 11. Meta-iodobenzylguanidine in children.
    Gelfand MJ
    Semin Nucl Med; 1993 Jul; 23(3):231-42. PubMed ID: 8378796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging of catecholamine-secreting tumours: uses of MIBG in diagnosis and treatment.
    Shapiro B
    Baillieres Clin Endocrinol Metab; 1993 Apr; 7(2):491-507. PubMed ID: 8489488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 131I-MIBG--a new agent in diagnosis and treatment of pheochromocytoma.
    Shapiro B; Sisson JC; Eyre P; Copp JE; Dmuchowski C; Beierwaltes WH
    Cardiology; 1985; 72 Suppl 1():137-42. PubMed ID: 4053121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Applications of [131I]m-iodobenzylguanidine ([131I]MIBG).
    Beierwaltes WH
    Int J Rad Appl Instrum B; 1987; 14(3):183-9. PubMed ID: 3312118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nuclear medicine diagnosis and treatment in pheochromocytoma and neuroblastoma].
    Fischer M
    Bildgebung; 1987-1989; 56(4):141-5. PubMed ID: 3271589
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.